New regenerative ligament could change ACL surgery
Disease control
ENROLLING_BY_INVITATION
This study compares a new regenerative ligament (CT-ACL001) to standard treatment for repairing a torn ACL in the knee. About 64 adults aged 18 to 45 who need ACL reconstruction will take part. The goal is to see if the new ligament works as well as the standard approach and caus…
Phase: NA • Sponsor: CoreTissue BioEngineering Inc. • Aim: Disease control
Last updated May 12, 2026 13:43 UTC